Cytoskeleton Associated Protein 2 (CKAP2) (C-Term) Peptide
CKAP2
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all CKAP2 products
- CKAP2 (Cytoskeleton Associated Protein 2 (CKAP2))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- GKAIVDSRSA QPKETSEERK ARLSEWKAGK GRVLKRPPNS VVTQHEPAGQ
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-CKAP2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- CKAP2 (Cytoskeleton Associated Protein 2 (CKAP2))
- Background
-
CKAP2 is a cytoskeleton-associated protein involved in mitotic progression.
Alias Symbols: DKFZp686L1238, FLJ10749, LB1, TMAP, se20-10
Protein Interaction Partner: YWHAG
Protein Size: 683 - Molecular Weight
- 77 kDa
- Gene ID
- 26586
- NCBI Accession
- NM_001098525, NP_001091995
- UniProt
- Q8WWK9
-
You are here:
